Author:
Yardumian Anne,Machin Samuel J.
Reference110 articles.
1. Addanizio VP, Fisher CA, Brenda AB, Jenkin BK, Strauss JF, Musial JF, Edmond LH (1985) Iloprost (ZK 36374), a stable analogue of prostacyclin, preserves platelets during simulated extra-corporeal circulation. J Thorac Cardiovasc Surg 89:926–933.
2. Aiken JW, Shebuski RJ (1980) Comparison in anaesthetised dogs of the anti-aggregatory and haemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6α-carba-PHI2 (car-bacyclin). Prostaglandins 19:629–643.
3. Aiken JW, Shebuski RJ, Miller OV, Gorman RR (1981) Endogenous prostacyclin contributes to the efficacy of thromboxane synthetase inhibitor for preventing coronary artery thrombosis. J Pharmacol Exp Ther 219:299–308.
4. Ambler J, Butler KD, Ku EC, Maguire ED, Smith JR, Wallis RB (1985) CGS 12970: a novel, long acting thromboxane synthetase inhibitor. Thromb Haemost 54:18 (abstr).
5. Arén C, Fedderson K, Râdegran K. (1983) Effects of prostacyclin infusion on platelet activation and postoperative blood loss in coronary bypass. Ann Thorac Surg 36:49–54.